Ownership history in FEDERATED HERMES, INC. · 5 quarters on record
This page tracks every 13F SEC filing in which FEDERATED HERMES, INC. reported a position in BICARA THERAPEUTICS INC (BCAX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 667 | +382 | +134.0% | 0.00% | $11K | $15.79 |
| 2025 Q2 | REDUCED | 285 | -11,715 | -97.6% | 0.00% | $3K | $9.29 |
| 2025 Q1 | ADDED | 12,000 | +4,000 | +50.0% | 0.00% | $156K | $13.03 |
| 2024 Q4 | UNCHANGED | 8,000 | — | 0% | 0.00% | $139K | $17.42 |
| 2024 Q3 | INITIATED | 8,000 | — | — | 0.00% | $204K | $25.47 |
As of 2025 Q4 — sorted by position size